Tracking babies born to mothers on epilepsy medication
NCT ID NCT06113237
Summary
This study aims to understand the safety of the epilepsy medication Epidiolex during pregnancy. Researchers will follow about 50 women who took the drug while pregnant and monitor their babies' health for the first year of life. The goal is to collect information on birth outcomes, infant development, and any pregnancy complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
United Biosource LLC
RECRUITINGMorgantown, West Virginia, 26508, United States
Conditions
Explore the condition pages connected to this study.